Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

DOI: 10.1080/2162402X.2016.1261779

Keywords: Head and neck cancer, immunotherapy, monoclonal antibody, PD-1, Tim-3

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text